	US 11,896,609 B2
	Pharmaceutical composition for treating inflammatory diseases comprising germanium telluride nanosheets coated with polyvinylpyrrolidone
Kyung-Hwa Yoo, Seoul (KR); Jun Ho Song, Seodaemun-gu (KR); Yong-Beom Park, Seocho-gu (KR); Sun-Mi Lee, Gangseo-gu (KR); Chin Hee Mun, Gyeonggi-do (KR); and Taejun Yoon, Seodaemun-gu (KR)
Assigned to Industry-Academic Cooperation Foundation, Seoul (KR)
Filed by Industry-Academic Cooperation Foundation, Seoul (KR)
Filed on Aug. 23, 2022, as Appl. No. 17/893,937.
Claims priority of application No. 10-2021-0111826 (KR), filed on Aug. 24, 2021.
Prior Publication US 2023/0080524 A1, Mar. 16, 2023
Int. Cl. A61K 33/24 (2019.01); A61K 9/00 (2006.01); A61K 9/28 (2006.01); A61K 9/51 (2006.01); A61K 33/00 (2006.01); A61K 33/04 (2006.01); A61P 1/04 (2006.01); A61P 29/00 (2006.01); A61P 37/00 (2006.01); A61K 47/32 (2006.01)

CPC A61K 33/24 (2013.01) [A61K 9/0029 (2013.01); A61K 9/0056 (2013.01); A61K 9/284 (2013.01); A61K 9/5115 (2013.01); A61K 33/00 (2013.01); A61K 33/04 (2013.01); A61P 1/04 (2018.01); A61P 29/00 (2018.01); A61P 37/00 (2018.01); A61K 47/32 (2013.01)]

7 Claims

1. A method of treating inflammatory diseases, comprising administering a pharmaceutically effective amount of a pharmaceutical composition to a subject in need thereof, wherein the pharmaceutical composition comprise a single layer of germanium telluride nanosheets coated with polyvinylpyrrolidone as an active ingredient.